sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
coxient filmuhúðuð tafla 30 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 30 mg
risperdal filmuhúðuð tafla 1 mg
janssen-cilag ab - risperidonum inn - filmuhúðuð tafla - 1 mg
ríson filmuhúðuð tafla 2 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 2 mg
ríson filmuhúðuð tafla 1 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 1 mg
ríson filmuhúðuð tafla 0,5 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 0,5 mg
risperidon krka filmuhúðuð tafla 2 mg
krka sverige ab - risperidonum inn - filmuhúðuð tafla - 2 mg
coxient filmuhúðuð tafla 60 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 60 mg
coxient filmuhúðuð tafla 90 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 90 mg
risperidon krka filmuhúðuð tafla 0,5 mg
krka sverige ab - risperidonum inn - filmuhúðuð tafla - 0,5 mg